Coronavirus Rheumatoid arthritis drug could help treat covid-19

Rheumatoid arthritis drug could help treat covid-19

-

The pharmaceutical company Eli Lilly announced that the combination of its rheumatoid arthritis treatment baricitinib with remdesivir reduced the recovery time in hospitalized patients with covid-19.

Eli Lilly explained that during the Adaptive Covid-19 Treatment Trial (ACTT-2), the researchers observed a reduction of approximately one day in the mean recovery time of patients treated with baricitinib combined with the substance remdesivir, compared to those who they were only treated with remdesivir, which is why they rated the finding as statistically significant.

The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institute of Health (NIH), included more than 1,000 patients and began on May 8 to evaluate the efficacy and safety of a dose. of 4 mg baricitinib plus remdesivir versus remdesivir in hospitalized patients with COVID-19.

According to Eli Lilly, the combination met the primary endpoint of reduced recovery time, which was defined as that the participant was well enough for discharge from hospital, meaning that they no longer needed supplemental oxygen or care continued in the hospital, or was no longer hospitalized on the 29th.

Eli Lilly reported that additional analysis is underway to understand other clinical outcome data, including mortality and safety data, and that NIAID is expected to publish full details of the study in a peer-reviewed journal.

Eli Lilly said he plans to discuss the emergency use authorization of the combination with the US Food and Drug Administration (FDA) and explore similar measures with other regulatory agencies for baricitinib as a treatment. of hospitalized patients with covid-19. If authorized, the company will propose that baricitinib be available through commercial channels and will work with hospitals and governments to ensure patient access.

Matthew Leisinghttps://www.newsalarms.com/
I cover market structure for News Alarms, specifically how the bond, derivatives, and cryptocurrency markets work or don't.

Latest news

How Athis Djeffson Has Dominated the Sales World

Sometimes the best entrepreneurs care just as much about helping others succeed as they do themselves. Athis Djeffson has...

DEFHOLD Unveils New Products in Time for Christmas

 The second-generation DeFi ecosystem, DEFHOLD, revealed plans this week to release some new products in the coming weeks. Specifically,...

Parents Are Shedding COVID-19-Fueled Weight Gain with Help of Fitness Personality Allegra Paris

The Quarantine 15 is a real reality for so many people around the world today, as people do their...

Angie Lee’s “Pays to Be Brave” Conference Started with a Handful of Attendees. Now it attracts Thousands of Women

You may have heard of Angie Lee by now - her wildly popular podcast, The Angie Lee Show, has...

No Fear: How AD4M Defies the Odds

The COVID-19 pandemic has made victims of company after company and industry after industry. It seems no one is...

ONESHOT KETO IS THE MIRACLE PILL YOU HAVE BEEN WAITING FOR

It is a challenging task for the average person to achieve their ideal body for reasons like a busy...

Must read

You might also likeRELATED
Recommended to you

%d bloggers like this: